Skip to main content

Table 1 Peptide peak intensities increased or decreased by the treatment of granulocyte-macrophage colony-stimulating factor (GM-CSF)

From: Implication of granulocyte-macrophage colony-stimulating factor induced neutrophil gelatinase-associated lipocalin in pathogenesis of rheumatoid arthritis revealed by proteome analysis

m/z

Ratio (treated/untreated)

Fraction

2,176.0

5.0

Cytosol

2,216.0

3.3

Cytosol

763.4

3.1

Cytosol

2,042.1

2.9

Cytosol

963.5

2.9

Cytosol

2,726.4

2.8

Cytosol

2,008.9

2.8

Cytosol

2,138.2

2.7

Cytosol

1,882.9

2.7

Cytosol

854.4

2.7

Cytosol

795.5

2.7

Cytosol

1,515.7

2.6

Cytosol

1,883.9

2.6

Cytosol

1,630.8

2.5

Cytosol

825.2

7.8

Organelle/membrane

1,791.0

4.0

Organelle/membrane

841.2

3.7

Organelle/membrane

2,191.3

3.7

Organelle/membrane

845.2

3.0

Organelle/membrane

2,690.6

2.9

Organelle/membrane

861.2

2.8

Organelle/membrane

2,045.2

2.7

Organelle/membrane

1,954.2

2.7

Organelle/membrane

1,813.0

2.6

Organelle/membrane

711.4

2.6

Organelle/membrane

1,479.9

2.5

Organelle/membrane

2,384.2

2.5

Organelle/membrane

841.1

2.6

Nuclei

792.5

0.3

Nuclei

1,577.9

2.9

Cytoskeleton

1,562.0

2.8

Cytoskeleton

1,569.9

2.6

Cytoskeleton

1,584.0

2.6

Cytoskeleton

1,231.8

2.6

Cytoskeleton

1,810.0

0.4

Cytoskeleton

2,064.1

0.4

Cytoskeleton

743.1

0.4

Cytoskeleton

2,053.1

0.4

Cytoskeleton

2,036.1

0.4

Cytoskeleton

1,750.0

0.3

Cytoskeleton

1,536.0

0.3

Cytoskeleton

2,621.4

0.3

Cytoskeleton

1,772.3

0.3

Cytoskeleton

1,762.0

0.3

Cytoskeleton

2,152.2

0.3

Cytoskeleton

2,035.1

0.3

Cytoskeleton

2,015.2

0.3

Cytoskeleton